В Г Барскова

3.0k total citations
37 papers, 598 citations indexed

About

В Г Барскова is a scholar working on Nephrology, Rheumatology and Epidemiology. According to data from OpenAlex, В Г Барскова has authored 37 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Nephrology, 11 papers in Rheumatology and 6 papers in Epidemiology. Recurrent topics in В Г Барскова's work include Gout, Hyperuricemia, Uric Acid (30 papers), Liver Disease Diagnosis and Treatment (5 papers) and Urticaria and Related Conditions (5 papers). В Г Барскова is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (30 papers), Liver Disease Diagnosis and Treatment (5 papers) and Urticaria and Related Conditions (5 papers). В Г Барскова collaborates with scholars based in United Kingdom, Russia and Norway. В Г Барскова's co-authors include Thomas Bardin, Tim Jansen, José Bravo Pimentão, Michael Doherty, Leonardo Punzi, Eliseo Pascual, Fernando Pérez-Ruiz, Pascal Richette, Burkhard F. Leeb and Till Uhlig and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Clinical Rheumatology.

In The Last Decade

В Г Барскова

29 papers receiving 562 citations

Peers

В Г Барскова

NEPHR

RHEUM

SURGE

OSM

José Bravo Pimentão Portugal

Narihito Tatsumoto Japan

J T Scott United Kingdom

Natallia Maroz United States

Ilona Kurnatowska Poland

J. Kutschera Austria

Tomas Hansen Sweden

Lida Tartaglione Italy

Daniel DeMoss United States

Saïd Kamel France

José Bravo Pimentão Portugal

В Г Барскова

354 ×0.9

NEPHR

382 ×1.0

RHEUM

165 ×1.0

SURGE

74 ×0.8

77 ×1.1

OSM

Citations per year, relative to В Г Барскова В Г Барскова (= 1×) peers José Bravo Pimentão

Countries citing papers authored by В Г Барскова

Since Specialization

Citations

This map shows the geographic impact of В Г Барскова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В Г Барскова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В Г Барскова more than expected).

Fields of papers citing papers by В Г Барскова

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В Г Барскова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В Г Барскова. The network helps show where В Г Барскова may publish in the future.

Co-authorship network of co-authors of В Г Барскова

This figure shows the co-authorship network connecting the top 25 collaborators of В Г Барскова. A scholar is included among the top collaborators of В Г Барскова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В Г Барскова. В Г Барскова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Елисеев, М. С., et al.. (2015). Time course of changes in the clinical manifestations of gout in men: Data of a 7-year retrospective follow-up. Terapevticheskii arkhiv. 87(5). 10–10. 12 indexed citations

Елисеев, М. С., et al.. (2013). GOUT OUTCOMES. A REVIEW OF LITERATURE. PART 1. GOUT: EPIDEMIOLOGY, RISK FACTORS, COURSE OF THE DISEASE WITH THE DEVELOPMENT OF CHRONIC TOPHUS FORM. SHILAP Revista de lepidopterología. 51(5). 569–569. 1 indexed citations

Zhang, Weiya, Michael Doherty, Eliseo Pascual, et al.. (2011). EULAR recommendations for calcium pyrophosphate deposition. Part II: Management. Annals of the Rheumatic Diseases. 70(4). 571–575. 136 indexed citations

Zhang, Weiya, Michael Doherty, Thomas Bardin, et al.. (2011). European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Annals of the Rheumatic Diseases. 70(4). 563–570. 335 indexed citations

Барскова, В Г. (2011). European League Against Rheumatism recommendations for terminologyand diagnosis of calcium pyrophosphate crystal deposition disease: Expert comment. SHILAP Revista de lepidopterología. 0(2). 6–6.

Барскова, В Г, et al.. (2011). Febuxostat is a novel drug in therapy for gout. SHILAP Revista de lepidopterología. 0(2). 52–52. 4 indexed citations

Елисеев, М. С., et al.. (2010). Carbohydrate metabolic disturbances in gout: detection rate and clinical featureS. SHILAP Revista de lepidopterología. 1 indexed citations

Jansen, Tim, Pascal Richette, Fernando Pérez-Ruiz, et al.. (2010). International position paper on febuxostat. Clinical Rheumatology. 29(8). 835–840. 34 indexed citations

Барскова, В Г. (2010). [Chronic gout: causes, clinical manifestations, treatment].. SHILAP Revista de lepidopterología. 82(1). 64–8. 5 indexed citations

10.

Елисеев, М. С., В Г Барскова, & E L Nasonov. (2009). Tumor necrosis factor α (TNFα) role in the development of metabolic disturbances and atherosclerosis and TNFα antagonists influence on them in patients with rheumatic diseases. Rheumatology Science and Practice. 0(2). 67–67. 1 indexed citations

11.

Барскова, В Г, et al.. (2009). USE OF REMICADE® IN PATIENTS WITH CHRONIC TOPHACEOUS GOUT: THEORETICAL RATIONALE AND ASSESSMENT OFOWN EXPERIENCE. Modern Rheumatology Journal. 0(2). 60–60. 1 indexed citations

12.

Волков, А. В., et al.. (2009). [Relationship between the intima-media complex thickness, the risk factors of cardiovascular diseases, and the level of C-reactive protein in gouty patients].. PubMed. 81(10). 45–9. 1 indexed citations

13.

Елисеев, М. С., et al.. (2008). Differentsial'naya diagnostika revmatoidnogo artrita i podagry. Modern Rheumatology Journal. 0(4). 39–39.

14.

Барскова, В Г, et al.. (2008). Place of topical therapy in rheumatology. Ketoprofen gel is a focus. Modern Rheumatology Journal. 0(3). 74–74. 1 indexed citations

15.

Барскова, В Г. (2008). Rational approaches to treating gout. Modern Rheumatology Journal. 0(1). 16–16.

16.

Барскова, В Г, et al.. (2007). Alcohol and the clinical picture of gout. Modern Rheumatology Journal. 0(1). 37–37. 2 indexed citations

17.

Елисеев, М. С., et al.. (2007). Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout. Modern Rheumatology Journal. 0(1). 31–31. 3 indexed citations

18.

Баранов, А. А., et al.. (2005). [Markers of vascular endothelium activation in gout].. PubMed. 77(5). 62–5. 1 indexed citations

19.

Барскова, В Г, et al.. (2004). Detection of sodium monourate crystals in biopsies of gastric mucosa in gout patients. SHILAP Revista de lepidopterología. 2 indexed citations

20.

Барскова, В Г, et al.. (2004). [The effectiveness and safety of nimesulide (nimesile) in patients with gouty arthritis].. PubMed. 82(12). 49–54. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact